Daniel D. Mikol
Amgen (United States)(US)Cardiome (Canada)(CA)
Publications by Year
Research Areas
Migraine and Headache Studies, Trigeminal Neuralgia and Treatments, Multiple Sclerosis Research Studies, Sympathectomy and Hyperhidrosis Treatments, Psychosomatic Disorders and Their Treatments
Most-Cited Works
- → A Controlled Trial of Erenumab for Episodic Migraine(2017)930 cited
- → Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial(2017)729 cited
- → ARISE: A Phase 3 randomized trial of erenumab for episodic migraine(2018)583 cited
- → Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial(2008)481 cited
- → Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial(2014)327 cited
- → Oligodendrocyte‐myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth(2002)260 cited